Ross Muken
Chief Executive Officer, Director · SOPHiA GENETICS SA
- 2026
- Oct 7, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ross Muken files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jurgi Camblong - $2.65M in SOPH purchases and sales in the last 12 months
- Zhenyu Xu - $761K in SOPH purchases and sales in the last 12 months
- Philippe Menu - $478K in SOPH purchases and sales in the last 12 months
- Abhimanyu Verma - $266K in SOPH purchases and sales in the last 12 months
- Manuela Valente - $159K in SOPH purchases and sales in the last 12 months
- Well Daan van - $142K in SOPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ross Muken?
Ross Muken is a corporate insider, tracked as Chief Executive Officer, Director of SOPHiA GENETICS SA (SOPH). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ross Muken submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Ross Muken been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($225K) across all tracked filings.
